A non-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks-Reference-Cited by-同舟云学术

A non-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks

Published:2013-04-19 Issue:6 Volume:73 Page:1071-1078
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

den Uyl Debby,ter Wee Marieke,Boers Maarten,Kerstens Pit,Voskuyl Alexandre,Nurmohamed Mike,Raterman Hennie,van Schaardenburg Dirkjan,van Dillen Nancy,Dijkmans Ben,Lems Willem

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference25 articles.

1. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study;Korpela;Arthritis Rheum,2004

2. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies;Lard;Am J Med,2001

3. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group;Mottonen;Lancet,1999

4. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial;Bakker;Ann Intern Med,2012

5. Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study;Bukhari;Arthritis Rheum,2003

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medikamentöse Rheumatherapie;Praxis Handreha;2023-10

2. Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?;Annals of the Rheumatic Diseases;2023-08-22

3. Revisiting the question of the safety of glucocorticoids use of in the treatment of rheumatoid arthritis;Modern Rheumatology Journal;2023-07-13

4. Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis;Annals of the Rheumatic Diseases;2022-11-21

5. Favourable effect of a ‘second hit’ after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial;Rheumatology;2022-10-07